Publications for Sverre Sörenson
Co-author map based on ISI articles 2007-
Publications mentioned in social media 1 times*
Journal Articles
Sverre Sörenson, Helena Fohlin, Andrea Lindgren, Magnus Lindskog, Bengt Bergman, Christer Sederholm, Lars Ek, Kristina Lamberg and Birgitta Clinchy
Predictive role of plasma vascular endothelial growth factor for the effect of celecoxib in advanced non-small cell lung cancer treated with chemotherapy
European Journal of Cancer, 2013, 49(1), 115-120.
Fulltext  |
Andrea Koch, Bengt Bergman, Erik Holmberg, Christer Sederholm, Lars Ek, Jaroslaw Kosieradzki, Kristina Lamberg, Lars Thaning, Sven-Olof Ydreborg and Sverre Sörenson
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
European Journal of Cancer, 2011, 47(10), 1546-1555.
Web of Science® Times Cited: 6 |
Andrea Koch, Bertil Gustafsson, Helena Fohlin and Sverre Sörenson
Cyclooxygenase-2 expression in lung cancer cells evaluated by immunocytochemistry
Diagnostic Cytopathology, 2011, 39(3), 188-193.
Web of Science® Times Cited: 4 |
Andrea Koch, Helena Fohlin and Sverre Sörenson
Prognostic significance of C-reactive protein and smoking in patients with advanced non-small cell lung cancer treated with first-line palliative chemotherapy.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2009, 4(3), 326-32.
Web of Science® Times Cited: 25 |
Sverre Sörenson
Svenska lungcancermötet 2009: Ny behandling för komorbida lungcancerpatienter
Onkologi i Sverige, 2009, (4), 74-77.
|
Christian von Plessen, Trond-Eirik Strand, Tore Wentzel-Larsen, Ernst Omenaas, Nils Wilking, Stein Sundstrøm and Sverre Sörenson
Effectiveness of third generation chemotherapy on the survival of patients with advanced non-small cell lung cancer - a national study
Thorax, 2008, , .
|
Andreas Hermes, Bengt Bergman, Roy Bremnes, Lars Ek, Sverre Fluge, Christer Sederholm, Stein Sundstrøm, Lars Thaning, Jan Vilsvik, Ulf Aasebø and Sverre Sörenson
Irinotecan plus carboplatin versus oral etoposide plus carboplatin in extensive small-cell lung cancer: a randomized phase III trial
Journal of Clinical Oncology, 2008, 26(26), 4261-4267.
|
MH Cullen, P Zatloukal, Sverre Sörenson, S Novello, JR Fischer, AA Joy, M Zereu, P Peterson, CM Visseren-Gruf and N Iscoe
A Randomized phase III trial comparing standard and high-dose pemetrexed as second-line treatment in patients with locally advanced or metastatic non-small-cell lung cancer
Annals of Oncology, 2008, 19(5), 939-945.
Web of Science® Times Cited: 38 |
Sverre Sörenson
Ny indikation för profylaktisk hjärnbestrålning vid småcellig lungcancer?
Onkologi i Sverige, 2007, (4), 62-63.
|
C von Plessen, B Bergman, O Andresen, RM Bremnes, S Sundström, M Gilleryd, RM Stephens, J Vilsvik, U Aasebö and Sverre Sörenson
Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer
British Journal of Cancer, 2006, 95(8), 966-973.
|
Michael Bergqvist, Sverre Sörenson, Baniel Brattström, Tony Mok and Roger Henriksson
Role of non-taxane-containing chemotherapy in advanced non-small cell lung cancer
American Journal of Cancer, 2006, 5(4), 223-244.
|
Conference Articles
Ph.D. Theses
Reports
* Social media data based on publications from 2011 to present and with a DOI; data delivered by Altmetric.com.
Ph.D., Lic. Theses
